circATP8A1, a potential prognostic biomarker and therapeutic target for gastric cancer, induces macrophage M2 polarisation and gastric cancer progression through the circATP8A1/miR-1-3p/STAT6 axis [14]. This evidence concerns the gene STAT6 and gastric cancer.